Pituitary Ischemic Apoplexy in a Young Woman Using Oral Contraceptives: A Case Report

Estrogen is suggested to be one of the plausible risk factors for pituitary hemorrhagic apoplexy through pituitary hyperemia. We experienced a 33-year-old woman with pituitary ischemic apoplexy of a nonfunctional macroadenoma under oral contraceptive use. Our case indicates that hypercoagulable stat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of stroke and cerebrovascular diseases 2013-11, Vol.22 (8), p.e643-e644
Hauptverfasser:	Kobayashi, Junpei, MD, Miyashita, Kotaro, MD, Tamanaha, Tamiko, MD, Kobayashi, Norikata, MD, Iihara, Koji, MD, Nagatsuka, Kazuyuki, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoma - complications Adenoma - diagnosis Adult Blood Coagulation - drug effects Cardiovascular Contraceptives, Oral, Combined - adverse effects Contraceptives, Oral, Hormonal - adverse effects corticotropin estrogen Female headache Humans Magnetic Resonance Imaging Neurology Pituitary Pituitary Apoplexy - chemically induced Pituitary Apoplexy - diagnosis Pituitary Apoplexy - therapy Pituitary Neoplasms - complications Pituitary Neoplasms - diagnosis Predictive Value of Tests Risk Factors thyrotropin Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Estrogen is suggested to be one of the plausible risk factors for pituitary hemorrhagic apoplexy through pituitary hyperemia. We experienced a 33-year-old woman with pituitary ischemic apoplexy of a nonfunctional macroadenoma under oral contraceptive use. Our case indicates that hypercoagulable state, but not hyperemia, associated with estrogen may promote pituitary ischemic apoplexy.
ISSN:	1052-3057 1532-8511
DOI:	10.1016/j.jstrokecerebrovasdis.2013.03.030